tiprankstipranks
Esperion (ESPR)
NASDAQ:ESPR
US Market
ESPR
Esperion
RESEARCH TOOLSreports
Want to see ESPR full AI Analyst Report?

Esperion (ESPR) Stock News & Sentiment

1,666 Followers
AI Models Turn More Positive on Esperion as ARCHIMED Buyout Drives Upside
Premium
AI Analyst Ratings
AI Models Turn More Positive on Esperion as ARCHIMED Buyout Drives Upside
2d ago
ESPR
Esperion Stock Surges Onto Analysts’ Trending Radar
Premium
Weekend Updates
Esperion Stock Surges Onto Analysts’ Trending Radar
3d ago
ESPR
Esperion agrees to $1.1 billion ARCHIMED buyout
Premium
Company Announcements
Esperion agrees to $1.1 billion ARCHIMED buyout
3d ago
8K
ESPR
Esperion Therapeutics: Reinforced Buy Rating on Strengthened Investment Story and Conference-Driven Upside Catalysts
Premium
Ratings
Esperion Therapeutics: Reinforced Buy Rating on Strengthened Investment Story and Conference-Driven Upside Catalysts
21d ago
ESPR
Esperion Completes Corstasis Acquisition, Expands Cardiovascular Portfolio
Premium
Company Announcements
Esperion Completes Corstasis Acquisition, Expands Cardiovascular Portfolio
1M ago
8K
ESPR
Esperion Therapeutics Earnings Call Signals Expansion
Premium
Company Announcements
Esperion Therapeutics Earnings Call Signals Expansion
1M ago
ESPR
Esperion Therapeutics: CLEAR Outcomes Stroke Data and Commercial Momentum Underscore Buy-Rated Cardiovascular Franchise
Premium
Ratings
Esperion Therapeutics: CLEAR Outcomes Stroke Data and Commercial Momentum Underscore Buy-Rated Cardiovascular Franchise
1M ago
ESPR
More ESPR News >

ESPR News on the Web

Esperion Therapeutics: Reinforced Buy Rating on Strengthened Investment Story and Conference-Driven Upside Catalysts
TipRanks News
Neutral
Esperion Therapeutics (ESPR) Down 10% Since Last Earnings Report: Can It Rebound?
Zacks
Neutral
Analysts Offer Insights on Healthcare Companies: Esperion (ESPR), PROCEPT BioRobotics (PRCT) and Vericel (VCEL)
TipRanks News
Bullish
Esperion Completes Corstasis Acquisition, Expands Cardiovascular Portfolio
TipRanks News
Neutral
Esperion, Athyrium Capital enter $50M royalty financing agreement
TipRanks News
Bullish
Esperion Therapeutics Earnings Call Signals Expansion
TipRanks News
Bullish
Esperion Therapeutics: CLEAR Outcomes Stroke Data and Commercial Momentum Underscore Buy-Rated Cardiovascular Franchise
TipRanks News
Bullish
Analysts Have Conflicting Sentiments on These Healthcare Companies: Passage Bio (PASG), Phreesia (PHR) and Esperion (ESPR)
TipRanks News
Bearish

News Score - Last 7 Days

Neutral
ESPR
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.75 articles
News Sentiment
This Week50%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ESPR’s Media Buzz Sentiment?
1 articles about ESPR were published this week. In an average week, 2.75 articles are published.
    What is ESPR’s weekly average amount of articles?
    In an average week, 2.75 articles about ESPR are published.
      What is ESPR’s News Sentiment?
      50% of articles about ESPR were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week